BFRIW vs CLOV · rev $37.3M vs rev $1.37B
Biofrontera Inc. Warrants (BFRIW) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Biofrontera Inc. Warrants (BFRIW) is a drug manufacturers - specialty & generic company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported BFRIW revenue for 2024-12-31 was $37.3M. Net income was -$17.8M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. BFRIW currently screens at market cap $0.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
BFRIW currently screens at market cap $0. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the BFRIW and CLOV stock pages for the full models.
Not investment advice.